InsiderDirector
Howard G. Welgus Insider Trading Activity
Every SEC Form 4 transaction reported by Howard G. Welgus, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Howard G. Welgus buying or selling?
Howard G. Welgus reported 0 open-market buys ($0) and 57 sells ($6.7M) across 57 Form 4 filings at 1 company — a net selling position of $6.7M.
Source: SEC EDGAR Form 4
What stands out
- All 57 of Howard G. Welgus's Form 4 filings are for one company, Arcutis Biotherapeutics, Inc. (ARQT).
- The most recent Form 4 was accepted on Sep 17, 2026 (31 days ago).
- In the last 12 months: no open-market purchases and 11 sales ($2.2M).
- The largest open-market sale in the last 12 months was $302.1K of Arcutis Biotherapeutics, Inc. (ARQT) on Dec 3, 2025. SEC ↗
Key Statistics (as of Sep 17, 2026)
Total Form 4 filings
57
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (57)
$6.7M
Insider sentiment
Net sellingNet insider flow of $6.7M in net selling, filed between Aug 5, 2020 – Sep 17, 2026.
Companies Howard G. Welgus files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | ARQTArcutis Biotherapeutics, Inc. | 57 |
Recent Howard G. Welgus transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | ARQT | Director | Sale | 4.7K | $114.4K | SEC ↗ |
| Aug 19, 2026 | ARQT | Director | Sale | 4.7K | $123.8K | SEC ↗ |
| Jul 17, 2026 | ARQT | Director | Sale | 4.7K | $127.3K | SEC ↗ |
| Jun 18, 2026 | ARQT | Director | Sale | 4.7K | $116.3K | SEC ↗ |
| May 6, 2026 | ARQT | Director | Sale | 7.1K | $164.2K | SEC ↗ |
| Apr 3, 2026 | ARQT | Director | Sale | 10.0K | $238.8K | SEC ↗ |
| Mar 4, 2026 | ARQT | Director | Sale | 10.0K | $256.5K | SEC ↗ |
| Feb 5, 2026 | ARQT | Director | Sale | 10.0K | $250.5K | SEC ↗ |
| Jan 6, 2026 | ARQT | Director | Sale | 10.0K | $289.6K | SEC ↗ |
| Dec 3, 2025 | ARQT | Director | Sale | 10.0K | $302.1K | SEC ↗ |
| Nov 5, 2025 | ARQT | Director | Sale | 10.0K | $252.7K | SEC ↗ |
| Oct 3, 2025 | ARQT | Director | Sale | 10.0K | $189.2K | SEC ↗ |
| Sep 4, 2025 | ARQT | Director | Sale | 10.0K | $156.4K | SEC ↗ |
| Aug 5, 2025 | ARQT | Director | Sale | 10.0K | $143.0K | SEC ↗ |
| Jul 2, 2025 | ARQT | Director | Sale | 9.2K | $127.4K | SEC ↗ |
| Jun 20, 2025 | ARQT | Director | Sale | 10.1K | $135.6K | SEC ↗ |
| May 5, 2025 | ARQT | Director | Sale | 10.0K | $146.4K | SEC ↗ |
| Apr 3, 2025 | ARQT | Director | Sale | 10.0K | $151.2K | SEC ↗ |
| Mar 5, 2025 | ARQT | Director | Sale | 10.0K | $130.0K | SEC ↗ |
| Feb 5, 2025 | ARQT | Director | Sale | 10.0K | $127.1K | SEC ↗ |
| Jan 6, 2025 | ARQT | Director | Sale | 10.0K | $146.7K | SEC ↗ |
| Dec 3, 2024 | ARQT | Director | Sale | 10.0K | $125.1K | SEC ↗ |
| Nov 5, 2024 | ARQT | Director | Sale | 10.0K | $86.5K | SEC ↗ |
| Oct 3, 2024 | ARQT | Director | Sale | 10.0K | $92.6K | SEC ↗ |
| Sep 5, 2024 | ARQT | Director | Sale | 10.0K | $107.7K | SEC ↗ |
Showing the 25 most recent filings of 57. Screen every filing.
Howard G. Welgus insider trading FAQ
Is Howard G. Welgus buying or selling?
Across 57 SEC Form 4 filings, Howard G. Welgus reported 0 open-market purchases totaling $0 and 57 sales totaling $6.7M — a net selling position of $6.7M.
Which companies does Howard G. Welgus file Form 4s for?
Howard G. Welgus has reported insider transactions at 1 company, most often Arcutis Biotherapeutics, Inc. (ARQT).
How far back does Howard G. Welgus's filing history go?
Trabud holds Howard G. Welgus's SEC Form 4 filings from Aug 5, 2020 – Sep 17, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Howard G. Welgus's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Howard G. Welgus and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener